Presented by BioPharm Process Associates…

We had some decent size financings today…let’s take a look:

• Canada’s biOasis Technologies (TSX.V: BTI) says it’s closed its private placement which it announced on April 16, 2009. BTI has issued a total of 1,000,000 units at a price of $0.50 per unit for gross proceeds of $500,000. Each unit consists of one common share and one common share purchase warrant. Each warrant is exercisable into one common share for a period of one year at a price of $0.60 per share. The funds will be used to advance the company’s research projects and provide working capital. BTI is working on a biomarker for the diagnosis of Alzheimer’s disease based on a blood serum test for concentration levels of p97 (Melanotransferrin). Of note, the company keeps a blog right here, which we found very useful. We like the idea of companies writing about their thought process, expertise and research. Kudos. [TradingMarkets]

• miRagen Therapeutics said it secured a $4M extension of its $8M Series A, bringing its total funding to $12M. miRagen was able to bring in some heavy hitters, including Amgen Ventures, Broadview Ventures and The Peierls Foundation to join founding investors Atlas Venture and Boulder Ventures. miRagen’s technology focuses on microRNA (miRNA) therapeutics for cardiovascular and muscle diseases. [Genetic Engineering & Biotechnology News]

• Versartis, Inc. announced that it closed a Series A financing with an initial commitment of $11M (EUR 7.9 M) from Index Ventures. Versartis is a joint venture between Amunix, Inc. and Index Ventures and utilizes Amunix’s recombinant PEGylation (rPEG) technology to modify therapeutic proteins. The company says it already has preclinical proof-of-concept for three product candidates: exenatide and IL-1ra for diabetes, and hGH for growth hormone deficiency. [Genetic Engineering & Biotechnology News]

• Finally, Phil Frost backed-OPKO Health (AMEX: OPK) raised $31M in a private placement from some big, yet low-key backers, including Vector Group, Chung Chia Company Limited, Grandtime Associates Limited, Gold Sino Assets Limited, Oracle Partners, LP, Oracle Institutional Partners, LP and Nora Real Estate S.A. [BusinessWire]

Anonymous Tip? Comments? Contact us at: hr@iguanabio.com

Related Posts